Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

The redox-active site of thioredoxin is directly involved in apoptosis signal-regulating kinase 1 binding that is modulated by oxidative stress

K. Psenakova, R. Hexnerova, P. Srb, V. Obsilova, V. Veverka, T. Obsil

. 2020 ; 287 (8) : 1626-1644. [pub] 20191103

Language English Country Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

E-resources Online Full text

NLK Free Medical Journals from 2005 to 1 year ago
Medline Complete (EBSCOhost) from 2005-01-01 to 1 year ago
Wiley Free Content from 2005 to 1 year ago

Apoptosis signal-regulating kinase 1 (ASK1) is a ubiquitously expressed mitogen-activated protein kinase kinase kinase 5, which mediates various stress signals including oxidative stress. The catalytic activity of ASK1 is tightly controlled by oligomerization and binding of several cofactors. Among these cofactors, thioredoxin stands out as the most important ASK1 inhibitor, but only the reduced form of thioredoxin inhibits ASK1 by direct binding to its N-terminal domain. In addition, oxidation-driven thioredoxin dissociation is the key event in oxidative stress-mediated ASK1 activation. However, the structural mechanism of ASK1 regulation by thioredoxin remains unknown. Here, we report the characterization of the ASK1 domain responsible for thioredoxin binding and its complex using NMR spectroscopy and chemical cross-linking, thus providing the molecular basis for ASK1: thioredoxin complex dissociation under oxidative stress conditions. Our data reveal that the N-terminal domain of ASK1 adopts a fold resembling the thioredoxin structure while retaining substantial conformational plasticity at the thioredoxin-binding interface. Although oxidative stress induces relatively moderate structural changes in thioredoxin, the formation of intramolecular disulfide bridges leads to a considerable conformational rearrangement of the thioredoxin-binding interface on ASK1. Moreover, the cysteine residue at position 250 of ASK1 is the key element of this molecular switch. Finally, our results show that the redox-active site of thioredoxin is directly involved in ASK1 binding that is modulated by oxidative stress, thereby identifying a key target for the structure-based drug design.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012746
003      
CZ-PrNML
005      
20230519095747.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/febs.15101 $2 doi
035    __
$a (PubMed)31623019
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Psenakova, Katarina $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic $u Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic
245    14
$a The redox-active site of thioredoxin is directly involved in apoptosis signal-regulating kinase 1 binding that is modulated by oxidative stress / $c K. Psenakova, R. Hexnerova, P. Srb, V. Obsilova, V. Veverka, T. Obsil
520    9_
$a Apoptosis signal-regulating kinase 1 (ASK1) is a ubiquitously expressed mitogen-activated protein kinase kinase kinase 5, which mediates various stress signals including oxidative stress. The catalytic activity of ASK1 is tightly controlled by oligomerization and binding of several cofactors. Among these cofactors, thioredoxin stands out as the most important ASK1 inhibitor, but only the reduced form of thioredoxin inhibits ASK1 by direct binding to its N-terminal domain. In addition, oxidation-driven thioredoxin dissociation is the key event in oxidative stress-mediated ASK1 activation. However, the structural mechanism of ASK1 regulation by thioredoxin remains unknown. Here, we report the characterization of the ASK1 domain responsible for thioredoxin binding and its complex using NMR spectroscopy and chemical cross-linking, thus providing the molecular basis for ASK1: thioredoxin complex dissociation under oxidative stress conditions. Our data reveal that the N-terminal domain of ASK1 adopts a fold resembling the thioredoxin structure while retaining substantial conformational plasticity at the thioredoxin-binding interface. Although oxidative stress induces relatively moderate structural changes in thioredoxin, the formation of intramolecular disulfide bridges leads to a considerable conformational rearrangement of the thioredoxin-binding interface on ASK1. Moreover, the cysteine residue at position 250 of ASK1 is the key element of this molecular switch. Finally, our results show that the redox-active site of thioredoxin is directly involved in ASK1 binding that is modulated by oxidative stress, thereby identifying a key target for the structure-based drug design.
650    12
$a apoptóza $7 D017209
650    _2
$a vazebná místa $7 D001665
650    _2
$a lidé $7 D006801
650    _2
$a MAP kinasa-kinasa-kinasa 5 $x antagonisté a inhibitory $x metabolismus $7 D048848
650    _2
$a magnetická rezonanční spektroskopie $7 D009682
650    _2
$a molekulární modely $7 D008958
650    _2
$a oxidace-redukce $7 D010084
650    12
$a oxidační stres $7 D018384
650    _2
$a inhibitory proteinkinas $x farmakologie $7 D047428
650    _2
$a thioredoxiny $x chemie $x metabolismus $7 D013879
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hexnerova, Rozalie $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Srb, Pavel $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic
700    1_
$a Obsilova, Veronika $u Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic
700    1_
$a Veverka, Václav, $u Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Prague, Czech Republic $u Department of Cell Biology, Faculty of Science, Charles University, Prague, Czech Republic $d 1973- $7 xx0301322
700    1_
$a Obsil, Tomas $u Department of Physical and Macromolecular Chemistry, Faculty of Science, Charles University, Prague, Czech Republic $u Department of Structural Biology of Signaling Proteins, Division BIOCEV, Institute of Physiology of the Czech Academy of Sciences, Vestec, Czech Republic
773    0_
$w MED00008414 $t The FEBS journal $x 1742-4658 $g Roč. 287, č. 8 (2020), s. 1626-1644
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31623019 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20230519095740 $b ABA008
999    __
$a ok $b bmc $g 1650998 $s 1133125
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 287 $c 8 $d 1626-1644 $e 20191103 $i 1742-4658 $m The FEBS journal $n FEBS J $x MED00008414
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...